Patents by Inventor Scott Dax

Scott Dax has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tricyclic delta-opioid modulators
    Publication number: 20060030585
    Abstract: The invention is directed to delta opioid receptor modulators. More specifically, the invention relates to tricyclic ?-opioid modulators. Pharmaceutical and veterinary compositions and methods of treating mild to severe pain and various diseases using compounds of the invention are also described.
    Type: Application
    Filed: August 2, 2005
    Publication date: February 9, 2006
    Inventors: Scott Dax, Bart DeCorte, Li Liu, Mark McDonnell, James McNally
  • 3a,4,5,9b-tetrahydro-1H-benz[e]indol-2-yl amine-derived neuropeptideYreceptors ligands useful in the treatment of obesity and other disorders
    Patent number: 6987188
    Abstract: Compounds of the formula: are disclosed as ligands for neuropeptide Y receptors and as such are useful in the treatment of obesity and disorders of the central nervous system.
    Type: Grant
    Filed: July 28, 2004
    Date of Patent: January 17, 2006
    Inventors: Scott Dax, James McNally
  • Aminotetralin-derived urea modulators of vanilloid VR1 receptor
    Publication number: 20050187291
    Abstract: This invention is directed to vanilloid receptor VR1 ligands. More particularly, this invention relates to ?-aminotetralin-derived ureas that are potent antagonists or agonists of VR1 which are useful for the treatment and prevention of inflammatory and other pain conditions in mammals.
    Type: Application
    Filed: January 28, 2005
    Publication date: August 25, 2005
    Inventors: Ellen Codd, Scott Dax, Michele Jetter, Mark McDonnell, James McNally, Mark Youngman
  • Non-peptidic NPY Y2 receptor inhibitors
    Publication number: 20050070534
    Abstract: The invention provides novel non-peptidic NPY Y2 receptor inhibitors useful in treating or preventing: anxiolytic disorders or depression; injured mammalian nerve tissue; conditions responsive to treatment through administration of a neurotrophic factor; neurological disorders; bone loss; substance related disorders; obesity; or an obesity-related disorder. Compounds of the invention are also useful in modulating endocrine functions, particularly endocrine functions controlled by the pituitary and hypothalamic glands, and are therefore useful in the treatment or prevention of inovulation and infertility.
    Type: Application
    Filed: September 24, 2004
    Publication date: March 31, 2005
    Inventors: Nicholas Carruthers, Wenying Chai, Scott Dax, Jill Jablonowski, Xiaobing Li, Timothy Lovenberg, William Murray, Dale Rudolph, Mark Seierstad, Mark Youngman
  • 3a,4,5,9b-tetrahydro-1H-benz[e]indol-2-yl amine-derived neuropeptideYreceptors ligands useful in the treatment of obesity and other disorders
    Publication number: 20050054709
    Abstract: Compounds of the formula: are disclosed as ligands for neuropeptide Y receptors and as such are useful in the treatment of obesity and disorders of the central nervous system.
    Type: Application
    Filed: July 28, 2004
    Publication date: March 10, 2005
    Inventors: Scott Dax, James McNally
  • 3a,4,5,9b-tetrahydro-1H-benz[e]indol-2-yl amine-derived neuropeptide Y receptors ligands useful in the treatment of obesity and other disorders
    Patent number: 6841552
    Abstract: Compounds of the formula: are disclosed as ligands for neuropeptide Y receptors and as such are useful in the treatment of obesity and disorders of the central nervous system.
    Type: Grant
    Filed: April 20, 2000
    Date of Patent: January 11, 2005
    Assignee: Ortho-McNeil Pharmaceutical, Inc.
    Inventors: Scott Dax, James McNally